Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00681681 · ClinicalTrials.gov registry record
Sex Differences in Vascular Markers of Stroke Risk
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 117
- Enrollment target
NCT00681681: Completed study, sponsored by Wake Forest University Health Sciences.
NCT00681681 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 117 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00681681 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 117 participants
- Enrollment target
Study Summary
The purposes of this study are to quantify and compare vascular function in men and women, and to determine the effect of age, race-ethnicity, cardiovascular risk factors, biological markers and hormonal markers on vascular measures to establish gender-specific models.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2008-02 |
| Est. Completion | 2013-01 |
What the finished NCT00681681 record still lists
NCT00681681 is an observational study that tracks outcomes without assigning an intervention. The registered 117 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00681681 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00681681 about?
NCT00681681 is a clinical study titled "Sex Differences in Vascular Markers of Stroke Risk". The purposes of this study are to quantify and compare vascular function in men and women, and to determine the effect of age, race-ethnicity, cardiovascular risk factors, biological markers and hormonal markers on vascular measures to establish gender-specific models.
What is the current status of trial NCT00681681?
This trial is currently completed. The enrollment target is 117 participants. The study started on 2008-02. Estimated completion is 2013-01.
Who is sponsoring clinical trial NCT00681681?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03539822 · 117 participants · Phase 1
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies
- NCT03786692 · 117 participants · Phase 2
Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC
- NCT04479696 · 117 participants · NA
Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
- NCT04940585 · 117 participants · NA
ROSE in Sunset Park
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia